Literature DB >> 10894600

Molecular and biological analysis of carcinoma of the small intestine: beta-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype.

M Murata1, K Iwao, Y Miyoshi, Y Nagasawa, T Ohta, K Shibata, K Oda, H Wada, S Tominaga, Y Matsuda, M Ohsawa, Y Nakamura, T Shimano.   

Abstract

The genetic mechanisms of carcinomas of the small intestine are not well understood. We report the results of analysis of genetic alterations in a case of small intestinal carcinoma. A tumor in the terminal ileum was resected in a 59-yr-old woman. Histologically, the tumor was classified as well-differentiated adenocarcinoma. We screened for genetic alterations in adenomatous polyposis coli (APC), beta-catenin, K-ras, and p53 genes, as well as microsatellite instability, which are known to be involved in colorectal tumorigenesis. The tumor exhibited somatic interstitial deletion of 425-bp, which included the entire exon 3 in beta-catenin gene. Immunohistochemical staining confirmed accumulation of aberrant beta-catenin protein in the cytoplasm and nuclei of the malignant tissue. Furthermore, a frameshift mutation in the transforming growth factor beta receptor type II gene with replication error phenotype was detected in the tumor DNA. In contrast, no genetic alterations were found in the APC, K-ras, and p53 genes. Our results suggested that both beta-catenin gene mutation and replication error phenotype might contribute to carcinogenesis of the small intestinal tumor in our case. This is the first report that activation of beta-catenin gene by somatic gene mutation is involved in the development of carcinoma of the small intestine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894600     DOI: 10.1111/j.1572-0241.2000.02123.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.

Authors:  Elena Osswald; Andreas Johne; Gabriele Laschinski; Farhad Arjomand-Nahad; Uwe Malzahn; Julia Kirchheiner; Thomas Gerloff; Christian Meisel; Przemyslaw M Mrozikiewicz; Jury Chernov; Ivar Roots; Karla Köpke
Journal:  Eur J Clin Pharmacol       Date:  2006-12-05       Impact factor: 2.953

Review 2.  Small bowel adenocarcinomas--existing evidence and evolving paradigms.

Authors:  Kanwal Raghav; Michael J Overman
Journal:  Nat Rev Clin Oncol       Date:  2013-07-30       Impact factor: 66.675

3.  TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma.

Authors:  Li Chen; Yuan-Yuan Zhu; Xiao-Juan Zhang; Gui-Lan Wang; Xin-Yu Li; Song He; Jian-Bin Zhang; Jian-Wei Zhu
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

4.  Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.

Authors:  T Aparicio; M Svrcek; A Zaanan; E Beohou; A Laforest; P Afchain; Emmanuel Mitry; J Taieb; F Di Fiore; J-M Gornet; A Thirot-Bidault; I Sobhani; D Malka; T Lecomte; C Locher; F Bonnetain; P Laurent-Puig
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.